|
|
|
|
UCLA Licensee CohBar, Inc. Completes $11.25 IPO
Pasadena, California - CohBar, Inc., a biotech company focused on developing mitochondiral-derived peptides-based therapeutics, announced that it completed an Initial Public Offering (IPO) on January 6, 2015 of 11,250,000 units at a price of US$1.00 per unit, providing gross proceeds of US$11,250,000. |
|
|
|
FDA Considers Kythera’s ATX-101 for Chin Fat Treatment
KYTHERA Biopharmaceuticals recently announced the Dermatology and Ophthalmic Drugs Advisory Committee of the FDA is scheduled to review KYTHERA’s New Drug Application (NDA) for ATX-101 (deoxycholic acid) for improvement in the appearance of moderate to severe submental fullness. |
|
|
|
NeuroInDx Unveils New Product Based on UCLA IP
The original idea was conceived and patented at UCLA, and further developed by NeuroInDx. UnipicKTM can be used as an add-on to nearly any inverted microscope for collecting single or multiple cells from culture dishes and slides, as well as for microdissecting subanatomical regions from tissue sections. |
|
|
|
UCLA Anderson Embraces Tech Boom, Entrepreneurs
FORTUNE Magazine: UCLA’s Anderson has gone through a transformation in recent years, becoming more closely tied to movements within the tech industries in L.A., Silicon Valley, and Seattle. The percentage of MBAs going into tech from UCLA has more than doubled in the past four years, eclipsing the 20.4% who took finance jobs and the 14.2% who went into consulting. |
|
|
Intellectual Property Announcements
New U.S. Patents Awarded
-
8,946,454 - Chemical framework compositions and methods of use | J. Stoddart, et al.
-
8,938,115 - Systems and methods for data fusion mapping estimation | A. Bertozzi, et al.
-
8,933,203 - Vault and vault-like carrier molecules | L. Rome, et al.
-
8,924,881 - Drill down clinical information dashboard | N. Martin, et al.
-
8,920,807 - Vault complexes for cytokine delivery | S. Dubinett, et al.
-
8,917,562 - Body voltage sensing based short pulse reading circuit | D. Markovic, et al.
~~~~
New UCLA Technologies Available for Licensing
SEARCH MORE UCLA TECHNOLOGIES
~~~~
|
|
|
|
Previous Issue - UCLA Invents |
- 2014 Roundup: UCLA Startup Funding and IP Licensing Highlights
- Kite Pharma, Amgen Forge $1B+ Cancer Immunotherapy Pact
- UCLA Startup NeuroSigma Granted FDA HUD Designation
- In March! UCLA Med Device Industry Partnering Conference
|
|
|
|
|
UCLA Invents Newsletter, Vol. 3, No. 6
How to Subscribe:
http://oip.ucla.edu/UCLAinvents
Send editorial comments and corrections to:
Bob Nidever, bnidever@research.ucla.edu
Contributors: Neil Bajpayee, Tara Kamin
UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
11000 Kinross Ave., Suite 200 | Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu
Copyright © 2014 The Regents of the University of California. All Rights Reserved.
|
|
|
|